Read about brain tumor diagnosis stories and the latest in brain tumor research.
Today, we’re announcing $2M in funding for a new pediatric brain cancer clinical trial. Dr. Mohamed Abdelbaki’s team is testing a new type of cancer immunotherapy in children with recurrent brain tumors, with funding from a CureSearch Catapult Award. August […]
CureSearch Research Funding DrivesNew Brain Cancer Treatments May is National Brain Tumor Awareness Month, highlighting a critical topic in the childhood cancer community as brain cancers account for 25% of all childhood and adolescent cancer diagnoses. Brain tumor types include medulloblastoma (the most common), high- and low-grade glioma, Primitive
For Immediate Release Contact: Michelle McGhee, Regional Manager, Development (240) 235-2210 | michelle.mcghee@curesearch.org Family of Alisa Finley to take part in children’s cancer research event Commerce City, CO – As a rising junior at Colby High School in Colby, Kan.,
Legacy of Cancer-Stricken Teen Inspires Participants, Volunteers for Upcoming Fundraiser Read More »
Richard Gilbertson, MD, PhD 2016-2019 Project: Targeted Therapies for High-risk Pediatric Brain Tumor Subtypes (Results of this project contributed to the launch of a phase 1 clinical trial testing combination therapies for malignant brain tumors, with Dr. Gilbertson’s research directly
Targeted Therapies for High-Risk Pediatric Brain Tumor Subtypes Read More »
Click Here to Donate to Joey’s Fund Today Joey’s Story Joey Keller was born on July 4, 2003 in Fort Wayne, Indiana. Little Joey entered the world around 9 pm, in the middle of a torrential downpour and huge booms
Eric Raabe, MD, PhD at Johns Hopkins University is a CureSearch Young Investigator studying the effect of a genetic mutation on the development of diffuse intrinsic pontine glioma (DIPG), a rare and difficult-to-treat brain tumor affecting children.
Researcher Seeks Answers to DIPG Read More »
“A new antibody therapy could dramatically improve outcomes for pediatric tumors.” What This Project Does Kathleen Sakamoto, MD, PhD Shelagh Galligan Professor in the School of MedicineStanford University A research team at Stanford University led by Drs. Kathleen Sakamoto and
Barriers to Treatment – Developing CD47 Antibody Therapy Read More »
In the last few years, researchers have learned much more about epigenetics. Epigenetics is the study of how and why certain genes get expressed. This knowledge has allowed scientists to better understand the mutations that cause cancer.
Overcoming Resistance in High Risk Medulloblastoma Read More »